AARON DAVIS

AARON DAVISCo-Founder and CEO, Boxer Capital

Aaron Davis is co-founder and chief executive officer of Boxer Capital, LLC. In 2005, after joining Tavistock Group as portfolio manager, Aaron scaled Tavistock Group’s public healthcare investing activities and formed Boxer Capital. Aaron leads the firm’s research team, deal structuring and portfolio management.

Prior to joining Tavistock Group, Aaron worked in the Global Healthcare Investment Banking and Private Equity Group at UBS Warburg, LLC. During this period, Aaron led strategic transactions for public and private biotechnology and medical device companies throughout their growth, advising on financing and mergers and acquisitions. Having also served in various roles with biotechnology and venture capital firms, Aaron has extensive expertise in investment analysis and in overseeing in-licensing activities within the pharmaceutical sector.

Aaron is currently chairman of the board of CiVi Biopharma, is a member of the board of directors of iTeos Therapeutics, Mirati Therapeutics, Odonate Therapeutics and Sojournix, Inc., and serves as a board observer for Black Diamond Therapeutics, Inc. and REVOLUTION Medicines, Inc. From 2006 to 2008, he served as a director of Kalypsys, Inc.

Aaron holds a Master of Science in biotechnology from Columbia University and a Bachelor of Arts in business administration from Emory University.